Total Payments
$17,029
2024 Payments
$9,310
Companies
16
Transactions
77
Medicare Patients
601
Medicare Billing
$55,002
Payment Breakdown by Category
Other$11,500 (67.5%)
Food & Beverage$3,600 (21.1%)
Travel$1,117 (6.6%)
Consulting$812.00 (4.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $6,720 | 10 | 39.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,780 | 4 | 28.1% |
| Food and Beverage | $3,600 | 58 | 21.1% |
| Travel and Lodging | $1,117 | 4 | 6.6% |
| Consulting Fee | $812.00 | 1 | 4.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lexicon Pharmaceuticals, Inc. | $8,972 | 24 | $0 (2024) |
| SCPHARMACEUTICALS INC. | $3,631 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $1,519 | 4 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $918.64 | 6 | $0 (2023) |
| Abbott Laboratories | $831.12 | 14 | $0 (2024) |
| ABIOMED | $485.94 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $165.45 | 3 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $133.45 | 2 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $133.24 | 5 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $81.42 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $9,310 | 25 | Lexicon Pharmaceuticals, Inc. ($5,419) |
| 2023 | $6,178 | 30 | Lexicon Pharmaceuticals, Inc. ($3,554) |
| 2022 | $562.78 | 13 | ABIOMED ($289.78) |
| 2021 | $977.67 | 9 | Novartis Pharmaceuticals Corporation ($812.00) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $28.09 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 12/03/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $3.15 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/17/2024 | Abbott Laboratories | AVEIR (Device) | Food and Beverage | In-kind items and services | $171.16 | General |
| Category: Cardiac Rhythm Management | ||||||
| 09/17/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,200.00 | General |
| Category: Cardiology | ||||||
| 09/17/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $55.94 | General |
| Category: Cardiology | ||||||
| 07/25/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Honoraria | Cash or cash equivalent | $560.00 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/19/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Honoraria | Cash or cash equivalent | $560.00 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/19/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Honoraria | Cash or cash equivalent | $560.00 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/19/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Honoraria | Cash or cash equivalent | $560.00 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/17/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/16/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $105.94 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $58.42 | General |
| 07/11/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $123.10 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 07/02/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Honoraria | Cash or cash equivalent | $560.00 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 06/20/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $124.64 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 06/18/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $96.23 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 06/13/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: Cardiology | ||||||
| 06/13/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $124.64 | General |
| Category: Cardiology | ||||||
| 05/07/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Honoraria | Cash or cash equivalent | $560.00 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 04/10/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $123.52 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 03/05/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Honoraria | Cash or cash equivalent | $560.00 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 02/20/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $123.51 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 02/14/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Honoraria | Cash or cash equivalent | $560.00 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 02/07/2024 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $116.75 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 02/05/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $450.00 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 21 | 23 | $6,302 | $1,807 |
| 2022 | 5 | 183 | 254 | $51,077 | $15,668 |
| 2021 | 6 | 261 | 404 | $77,760 | $25,738 |
| 2020 | 4 | 136 | 179 | $42,947 | $11,789 |
Total Patients
601
Total Services
860
Medicare Billing
$55,002
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 23 | $6,302 | $1,807 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 139 | $36,279 | $11,389 | 31.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 24 | $8,712 | $2,689 | 30.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 18 | $4,284 | $1,236 | 28.8% |
| 96374 | Injection of drug or substance into vein | Office | 2022 | 12 | 12 | $1,680 | $326.96 | 19.5% |
| J1940 | Injection, furosemide, up to 20 mg | Office | 2022 | 13 | 61 | $122.00 | $27.65 | 22.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 121 | 146 | $36,208 | $12,787 | 35.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 51 | 54 | $17,928 | $6,615 | 36.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 22 | 23 | $10,626 | $2,890 | 27.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 27 | 39 | $9,282 | $2,640 | 28.4% |
| 96374 | Injection of drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2021 | 20 | 26 | $3,484 | $745.68 | 21.4% |
| J1940 | Injection, furosemide, up to 20 mg | Office | 2021 | 20 | 116 | $232.00 | $60.00 | 25.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 34 | 67 | $16,013 | $4,637 | 29.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 20 | 20 | $9,180 | $2,681 | 29.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 50 | 59 | $9,735 | $2,249 | 23.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 32 | 33 | $8,019 | $2,222 | 27.7% |
About Benjamin Hocutt, AG-ACNP
Benjamin Hocutt, AG-ACNP is a Acute Care healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/24/2014. The National Provider Identifier (NPI) number assigned to this provider is 1063817773.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Benjamin Hocutt, AG-ACNP has received a total of $17,029 in payments from pharmaceutical and medical device companies, with $9,310 received in 2024. These payments were reported across 77 transactions from 16 companies. The most common payment nature is "Honoraria" ($6,720).
As a Medicare-enrolled provider, Hocutt has provided services to 601 Medicare beneficiaries, totaling 860 services with total Medicare billing of $55,002. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Location Greenville, NC
- Active Since 10/24/2014
- Last Updated 10/24/2014
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1063817773
Products in Payments
- Inpefa (Drug) $8,972
- FUROSCIX (Drug) $3,631
- VERQUVO (Drug) $1,519
- ENTRESTO (Drug) $918.64
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $545.99
- Impella (Device) $485.94
- AVEIR (Device) $171.16
- OPTIMIZER (Device) $133.45
- HeartMate 3 Left Ventricular Assist Device (Device) $93.39
- OPSUMIT (Drug) $70.72
- UPTRAVI (Drug) $62.52
- LifeVest (Device) $35.95
- XARELTO (Drug) $30.16
- Assure WCD (Device) $26.92
- CARDIOMEMS (Device) $20.58
- MICRA (Device) $18.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Greenville
Heather Bowers, Aprn, Agacnp-Bc, APRN, AGACNP-BC
Acute Care — Payments: $76,046
Acute Care $76,046
Kathryn Rarick
Acute Care — Payments: $6,321
Acute Care $6,321
Ashley Schneider, Aprn, APRN
Acute Care — Payments: $5,288
Acute Care $5,288
Lucretia Myers, Np, NP
Acute Care — Payments: $4,996
Acute Care $4,996
Mrs. Heather Day, Apn, APN
Acute Care — Payments: $4,363
Acute Care $4,363
Taylor Newton, Np, NP
Acute Care — Payments: $4,327
Acute Care $4,327